Amgen (AMGN) PT Raised to $352 at Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst David Risinger raised the price target on Amgen (NASDAQ: AMGN) to $352.00 (from $305.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
